Literature DB >> 11253861

New milestones achieved in fluoroquinolone safety.

G S Tillotson1, J Rybak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11253861     DOI： 10.1592/phco.21.3.358.34205

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  2 in total

1.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials.

Authors:  Vincent T Andriole; Daniel C Haverstock; Shurjeel H Choudhri
Journal:  Drug Saf       Date:  2005       Impact factor: 5.228
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.